MelanomaMembers of the Melanoma Program (MP) examine the basic mechanisms that govern melanoma development, progression, immune escape, and resistance to therapy, and translate laboratory discoveries into novel immunotherapies, molecularly targeted therapies, and combinations for patients with high-risk and advanced melanoma.

Read more about the Melanoma Program

See Program Members


Research Themes:

Immunology and Immunotherapy of Melanoma

Investigate the mechanisms governing melanoma progression and immune escape to develop improved immunotherapies

Melanoma Brain Metastasis

Develop more effective therapies and improved biomarkers of clinical outcome for patients with melanoma brain metastases

Melanoma Clinical Trials

Translate laboratory findings into novel investigator-initiated clinical trials with correlative studies